West Pharmaceutical Services Inc.

West Pharmaceutical Services is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The company's products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services. Proprietary Products segment provides proprietary packaging, containment and drug delivery products. Contract-Manufactured Products segment includes a variety of custom contract-manufacturing and assembly solutions.
  • TickerWST
  • ISINUS9553061055
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

Jake Strole

Morningstar | West Pharma's Wide Moat Supports Substantial Future Margin Expansion

Founded in 1923, West Pharmaceutical Services has spent the past 95 years building an impressive business that we think has been effective in constructing a wide economic moat. The success of the franchise has rested upon management's decision to focus on reinvesting behind the firm's core competency, namely, the manufacture of rubber-based components used in the packaging, storage, and administration of injectable therapeutics. Instead of utilizing the firm's balance sheet to acquire assets and expand its manufacturing capability into adjacent verticals, management has decided to fortify West...

Jake Strole

West Pharma's Wide Moat Supports Substantial Future Margin Expansion

Wide-moat West Pharmaceutical Services reported a strong start to its year with organic revenue expanding 11%, led by its high-value product portfolio that expanded nearly 20% on a reported basis, by our math. We'll probably bump up our $100 fair value estimate by a mid-single-digit percentage as we tweak our model to account for this better-than-expected growth. However, with the stock currently trading at over 40 times our 2019 adjusted earnings estimate, we have a hard time strongly recommend...

Jake Strole

Morningstar | West Pharma Starts 2019 Ahead of Expectations; Raising FVE

Wide-moat West Pharmaceutical Services reported a strong start to its year with organic revenue expanding 11%, led by its high-value product portfolio that expanded nearly 20% on a reported basis, by our math. We'll probably bump up our $100 fair value estimate by a mid-single-digit percentage as we tweak our model to account for this better-than-expected growth. However, with the stock currently trading at over 40 times our 2019 adjusted earnings estimate, we have a hard time strongly recommending the name. The firm's proprietary product franchise accelerated in the quarter, posting 9.4% org...

Jake Strole

West Pharma Starts 2019 Ahead of Expectations; Raising FVE

Wide-moat West Pharmaceutical Services reported a strong start to its year with organic revenue expanding 11%, led by its high-value product portfolio that expanded nearly 20% on a reported basis, by our math. We'll probably bump up our $100 fair value estimate by a mid-single-digit percentage as we tweak our model to account for this better-than-expected growth. However, with the stock currently trading at over 40 times our 2019 adjusted earnings estimate, we have a hard time strongly recommend...

Jake Strole

Morningstar | West's 2019 Outlook Falls Short, but Its Wide Moat Remains Intact

Founded in 1923, West Pharmaceutical Services has spent the past 95 years building an impressive business that we think has been effective in constructing a wide economic moat. The success of the franchise has rested upon management's decision to focus on reinvesting behind the firm's core competency, namely, the manufacture of rubber-based components used in the packaging, storage, and administration of injectable therapeutics. Instead of utilizing the firm's balance sheet to acquire assets and expand its manufacturing capability into adjacent verticals, management has decided to fortify West...

A director sold 21,000 shares at 99.010USD and

A director at West Pharmaceutical Services Inc sold 21,000 shares at 99.010USD and the significance rating of the trade was 70/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules...

Insider bought: Three Directors bought 1,570,840 shares at 0.050CAD.

Three Directors at Westridge Resources Inc bought 1,570,840 shares at 0.050CAD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. ...

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

ValuEngine Rating and Forecast Report for WST

GlobalData Department

West Pharmaceutical Services Inc (WST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company’s major products include primary packaging, containment solutions, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components, among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves biologic, generic, pharmaceutical, diagnostic, and medical device companies across the world. The company distributes ...

MarketLine Department

Catalent Inc - Strategy, SWOT and Corporate Finance Report

Catalent Inc - Strategy, SWOT and Corporate Finance Report Summary Catalent Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Catalent, Inc. (Catalent or ‘the company’) is a provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. The company classifies its business into three reportable segments:...

GlobalData Department

West Pharmaceutical Services Inc (WST) - Medical Equipment - Deals and Alliances Profile

Summary West Pharmaceutical Services Inc (West Pharmaceutical) manufactures components and delivery systems for injectable drugs and healthcare products. The company’s major products include primary packaging, containment solutions, cartridge systems and components, prefillable systems, reconstitution and transfer systems, drug delivery systems and specialty components, among others. It also offers contract manufacturing and analytical lab services. West Pharmaceutical serves biologic, generic, pharmaceutical, diagnostic, and medical device companies across the world. The company distributes ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch